Abstract
Pre-procedural use of statins is suggested to improve clinical outcomes in both short- and long-terms for patients with acute coronary syndrome who underwent percutanous coronary intervention [1,2]. Recent experimental and clinical studies indicate that statins have pleiotropic vascular protective effects beyond cholesterol reduction [3,4]. Endothelial function is one of the earliest abnormalities that can be detected in the development of atherosclerosis and contributes to predict the outcome of coronary heart disease [5–7].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
